Articles tagged with Cancer Screening
The Cell-CT platform detected lung cancer in patient sputum samples with a sensitivity of over 95% and specificity of 99.8%. The technology creates comprehensive 3D digital images of cells, making it possible to determine the presence or absence of cancer with great accuracy.
Researchers at the University of Twente in the Netherlands have developed a new imaging tool called the photoacoustic mammoscope, which uses a combination of infrared light and ultrasound to create a 3-D map of the breast. The device has shown promise in detecting breast cancer early, when it is most treatable.
A survey of 317 U.S. men and women aged 50-69 found that most patients are not being told about the possibility of overdiagnosis and overtreatment due to cancer screenings. Nearly 59% would continue screening despite learning it results in 10 overtreated individuals per life saved from cancer death.
A study from University of Texas Medical Branch found that more than 40% of men over 75 undergo PSA screening, despite no medical organization recommending it for this age group. The researchers suggest that decision-making by primary care physicians is a major reason for the continued high PSA rate.
A study by Yale researchers found that Medicare spent $447 million annually on PSA-based screenings for prostate cancer, with most of it going to men over 75. The cost variation was mainly due to follow-up tests, not the use of the PSA itself.
A new study by NYU Steinhardt researcher Niyati Parekh suggests that disturbances in body insulin and glucose levels are associated with an increased risk of obesity-related cancers. The research, which analyzed data from the Framingham Heart Study, recommends lifestyle changes to alleviate these disturbances as a cancer control tool.
A new analysis reveals that regular mammograms before age 50 significantly reduce breast cancer deaths in younger women. The study analyzed data from invasive breast cancers diagnosed between 1990 and 1999, finding that only 13% of cases occurred in women aged 70 or older.
A new clinical risk calculator software has been developed to accurately classify benign and malignant spots on lung scans of smokers. The software uses a prediction model that considers several factors, including size, age, family history, and location of the nodule, to predict the probability of cancer.
A 12-year study found CA-125 to have a 99.9% specificity in detecting high-grade invasive ovarian cancers at curable stages, while the test failed to detect two borderline cases. The study's results suggest CA-125 as a promising first step in early disease detection.
A new screening strategy for ovarian cancer has shown high specificity in detecting the disease before it becomes lethal. The two-stage approach incorporates changes in a blood protein called CA125 and has been found to have a positive predictive value of 40% for invasive ovarian cancer.
Researchers develop a new microfluidic chip that can capture over 90% of circulating tumor cells from patient blood, providing potential applications for cancer screenings, treatment assessments, and disease progression determination. The technique shortens processing time and improves efficiency compared to existing methods.
A new study published in Radiology found that digital tomosynthesis reduces the recall rate in breast cancer screening, particularly in younger women and those with dense breast tissue. The addition of tomosynthesis resulted in a 30 percent reduction in overall recall rate, compared to conventional mammography alone.
A scientific panel recommends personalized strategies to reduce cancer overtreatment by classifying indolent tumors and improving screening strategies. The goal is to detect consequential cancer while avoiding inconsequential disease.
A study found that many family caregivers of older adults with dementia are willing to consider stopping cancer screening, which can reduce patient burden, healthcare costs, and family caregiver distress. Caregivers are most open to discussions when focusing on quality of life and burdens and benefits for the person with dementia.
A new study suggests that STD clinics can provide essential access to cervical cancer screenings for underscreened women. The majority of women participating in the study were eager to receive the screening, and most reported not having had a pap smear in at least three years.
A recent study found that many obstetrician-gynecologists continue to provide annual cervical-cancer screenings despite updated guidelines. The research suggests less frequent screening every three years can retain most benefits while reducing harms and costs. Experts recommend a more balanced approach to cervical cancer screening.
Researchers from the University of Liverpool and University of the West of England have developed a device that can detect bladder cancer through urine scent analysis. The ODOREADER device analyzes chemicals in gas emitted from urine to produce a 'profile' that can be used to diagnose cancer cells in the bladder.
Researchers at H. Lee Moffitt Cancer Center have developed a new method to rapidly identify genetic changes in small protein fragments unique to melanoma cancer cells. The approach harnesses tumor-infiltrating lymphocytes, which have been shown to reduce cancerous lesions and improve outcomes.
A new study found that virtual colonoscopy screenings can be safely delayed for women by 5-10 years compared to men, with minimal impact on cancer detection rates. The findings suggest that women under 55 may only need to undergo screening every 10 years, while those over 60 can wait up to 5 years longer.
Researchers found that 30% of people with colorectal cancer did not act on genetic screening results, missing the diagnosis of Lynch syndrome. This study assesses the impact of routine screening for Lynch syndrome and highlights the importance of individuals taking action on test results.
A novel transcriptome-based classification of colon cancer has been developed, improving disease stratification based on clinicopathological variables and common DNA markers. The analysis identified six molecular subtypes associated with distinct clinical and pathological characteristics.
A study of veterans at high risk for developing lung cancer shows that low-dose computed tomography (LDCT) can effectively spot tiny lung nodules indicating the earliest stages of disease. LDCT uses less than a quarter of the radiation of a conventional CT scan, resulting in a higher detection rate compared to chest x-rays.
A new study suggests that digital direct radiography (DR) is significantly more effective than computed radiography (CR) in detecting breast cancer. DR detected 4.9 cancers per 1,000 mammograms, while CR's detection rate was 21% lower, with 3.4 cancers per 1,000 mammograms.
A new analysis found a significant link between Agent Orange exposure and high-grade prostate cancer among US Veterans. Exposure to the herbicide was associated with a 52% increase in overall risk of prostate cancer detection by biopsy, as well as a 75% increase in risk of high-grade prostate cancer.
A University of Michigan study found that despite strong recommendations to use decision aids, there is a lack of evidence on whether they work effectively. The researchers reviewed 73 decision aids for breast, cervical, colon, and prostate cancers but only half were evaluated for subsequent screening behavior.
A study from Yale University found that two views are better than one in 3D breast screening to ensure optimal cancer detection. The CC view achieves better compression and shows lesions clearer due to its ability to compress the breast tissue.
A new study reveals that breast ultrasound screening after mammography can detect an additional 3.4 cancers per thousand women screened in those with greater than 50% breast density. The detection rate is comparable to that of screening mammography for women with less dense breasts.
A Moffitt Cancer Center study found that minority groups, including blacks, Asians, and Hispanics, hold differing beliefs about cancer prevention and feel they are less likely to get cancer. The researchers concluded that more culturally relevant information is needed to reach these populations.
A new study suggests that nearly half of all deaths from prostate cancer can be predicted before age 50, based on PSA levels. Focusing testing on men at highest risk may improve the benefits and harms of screening.
The American Cancer Society's report emphasizes the importance of reducing tobacco use, improving nutrition and physical activity, and expanding cancer screening tests. The report notes significant declines in cigarette smoking prevalence but highlights concerns about heavy smoking, indoor tanning, and HPV vaccination coverage.
A Penn Medicine study found that computed tomography colonography (CTC) was used appropriately in asymptomatic Medicare patients. The study suggests that CTC may have expanded colorectal cancer screening beyond the population screened with standard optical colonoscopy.
A new study has identified genetic alterations in the RGS pathway as key factors linked to bladder cancer risk, recurrence, disease progression, and patient survival. The research found that specific variants were associated with increased or decreased risks, providing potential molecular markers for screening and treatment.
A study by Regenstrief Institute and Indiana University Center for Aging Research found that many older adults resist stopping cancer screenings, even when they may not be beneficial. The researchers suggest developing specific messages for older adults to address concerns about screening and trust in physicians.
A new study confirms the effectiveness of colonoscopy in preventing advanced colorectal cancer diagnoses, particularly for tumors on the right side of the colon. The study found a 70 percent reduction in risk for average-risk adults, supporting current medical recommendations.
Researchers used electronic health records to identify patients overdue for colon cancer screening and encouraged them to be screened. The centralized approach doubled on-time screening rates and saved health costs over two years.
A new study confirms colonoscopy is safe, with only a few cases of severe complications per 10,000 procedures. Regular screening can prevent colon cancer and significantly reduce mortality rates.
A new study estimates that LDCT screening for lung cancer can delay or prevent approximately 12,000 deaths each year in the United States. The potential benefits of widespread LDCT screening are significant, given that half of current smokers will die from smoking-related diseases.
A recent Mayo Clinic study found that using high-definition imaging tools during screening colonoscopies can increase adenoma detection rates by up to 25% in women and 41% in men. The study suggests that national benchmarks for detecting polyps may be too low, especially when using advanced technology.
A pioneering study published in The Lancet Oncology found that local volunteers increased early breast cancer detection rates in a low-income rural area. The study showed that 70% of women screened were diagnosed with benign lesions or successfully treated for breast cancer, significantly improving long-term survival chances.
A new study aims to determine the prevalence of abnormal anal cytology and high-risk HPV among women with a history of cervical pre-cancer or cancer. The researcher hopes to gather basic information to design larger studies that will analyze sensitivity and specificity of anal cytology and HPV testing.
The American Cancer Society recommends low-dose computed tomography (CT) screening for patients aged 55-74 with a 30-pack-year smoking history. A thorough discussion of benefits, limitations, and risks is essential before screening. Screening can reduce lung cancer mortality in high-risk groups.
A Moffitt study found Hispanics are nearly twice as likely to avoid cancer screenings due to fears and mistrust of medical professionals. The researchers suggest improving communication and building trust with patients is crucial for increasing screening rates, particularly among Hispanic and lower-income minorities.
A recent study published in JAMA Internal Medicine found that higher spending on breast cancer screenings does not result in improved outcomes for older women. The research team analyzed Medicare expenditures and screened female beneficiaries over two years, discovering substantial geographic variation in costs.
A recent study found that rural US residents are less likely to follow colorectal cancer screening guidelines due to the time required for travel and limited access to healthcare. The researchers also noted that lack of health insurance and primary care provider shortages contribute to this disparity.
Researchers have developed a simple breath analysis technique that can screen for colorectal cancer with an accuracy of over 75%. The method analyzes volatile organic compounds in exhaled breath, which are different in patients with cancer.
Researchers developed models from PLCO data to predict smoking status, finding that relapse and continued smoking are linked to demographic and tobacco-related characteristics. The models suggest variables like longer-term smokers, recent quitters, and pipe or cigar smokers are at higher risk for relapse.
A recent study from Stanford University School of Medicine found that increased use of colonoscopy screening may be responsible for the significant decrease in colorectal cancer incidence over the past decade. The study analyzed data from over 2 million patients and found a correlation between Medicare's extension of colonoscopy covera...
Researchers analyzed data from a national screening trial to understand characteristics of undetectable lung cancers. They found that these cancers were more common among males and those with a history of smoking, and were often small cell lung cancers at an advanced stage.
A systematic approach to improve screening rates for colorectal cancer resulted in a fourfold increase in screening among low-risk individuals. The protocol, which included introductory phone calls and mailed testing kits, saw CRC screening rates jump from 47 to 72 percent in three years.
A Swiss study found that colonoscopy with polypectomy significantly reduces colorectal cancer incidence and mortality. The screened group had 12 cases, while the non-screened group had 213 cases, resulting in lower cancer-related death rates.
A new study found that screening intervals between one and three years have similar outcomes for gastric cancer stages, but longer intervals lead to more advanced cancer at diagnosis. The researchers recommend a screening interval of every three years in high-risk regions.
A new study finds that rheumatoid arthritis (RA) patients receive regular cancer screenings, including breast, cervical, and colon cancer tests, at similar rates to the general population. The study's results challenge previous research suggesting RA patients receive fewer cancer screenings.
A new study by Jason Purnell finds that nearly 70% of 2-1-1 callers needed at least one cancer control service, with greater need in Missouri, North Carolina, Texas, and Washington. Callers were receptive to referrals for preventive services like mammography and HPV vaccination.
A computer-based algorithm can accurately predict seven-day heart failure mortality rates in emergency room patients. Researchers also found that childhood cancer survivors are at increased risk for gastrointestinal cancers starting as early as 5.5 years after diagnosis.
The John Theurer Cancer Center will present research on multiple myeloma and leukemia, including combination therapies and salvage therapy for acute myeloid leukemia. The center's focus on bolstering its research program is part of its continued effort to provide comprehensive cancer care.
A survey of primary care doctors found that many resist stopping routine PSA testing due to patient expectations and malpractice concerns. Researchers are working on a decision-making tool to help doctors make informed choices about prostate cancer screening.
The USPSTF recommends against PSA-based screening for all men regardless of age, citing significant harms associated with the test. The Task Force concludes that the benefits of screening do not outweigh the risks, which include unnecessary treatments and life-long adverse effects.
A systematic review found that low-dose computerized tomography (LDCT) screening can reduce lung cancer mortality rates among high-risk individuals. The study analyzed 8 randomized controlled trials and 13 cohort studies, with the National Lung Screening Trial demonstrating a significant benefit. However, potential harms of LDCT screen...
A web-based video instructional program significantly improves patient compliance with colonoscopy screenings, cutting no-show rates by up to 40%. The study found that patients who watched the video were more likely to arrive prepared and cancel appointments less frequently, leading to better outcomes for cancer detection and treatment.
Current colorectal cancer screening guidelines for individuals with first-degree relatives having precancerous colon polyps are not based on well-designed studies. A new systematic review calls for new research to measure the risk and identify modifying factors.